Skip to main content
logo
VISEN Pharmaceuticals (HKG:2561)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
18.53
-0.28 (-1.49%)
Oct 9, 2026, 11:22 AM HKT

VISEN Pharmaceuticals Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
34.060.142.78-1.67-2.3
Revenue Growth
24944.85%-95.10%---
Gross Profit
17.44-0.012.78-1.67-2.3
Operating Income
-222.46-239.82-174.18-139.3-359.29
Net Income
-239.51-253.42-182.24-249.57-288.97
Earnings Per Share
-2.21-2.44-1.95-2.67-
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
505.81632.65203.59347.78626.46
Total Debt
176.71176.992.363.656
Net Cash (Debt)
329.1455.66201.23344.13620.46
Net Cash Growth
-27.77%126.44%-41.53%-44.54%-
Net Cash Per Share
3.044.402.153.68-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-458.1-447.58-140.86-271.31-246.55
Capital Expenditures
-1.84-1.49-0.12-0.52-1.48
Free Cash Flow
-459.94-449.07-140.98-271.83-248.03
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
51.19%-7.35%100.00%--
Operating Margin
-653.11%-176338.97%-6272.16%--
Pretax Margin
-703.16%-186339.71%-6562.55%14953.27%12574.72%
Profit Margin
-703.16%-186339.71%-6562.55%--
FCF Margin
-1350.34%-330200.00%-5076.52%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
51.7322761.01---